medication | National Headache Foundation

Ketamine and Migraine

September 2023, Episode 163: Ketamine, it’s a controversial topic, but we hear about it in the migraine community when someone is intractable and not responding to other medications. Lindsay Weitzel, PhD asks headache specialist Fred Cohen, MD all about why…

News Edition December 2022

December 2022, Episode 141: Lindsay Weitzel, Ph.D., talks to Dr. Tim Smith, MD, about some of the latest published studies related to headache. What new side effect has been linked to CGRP medications? What migraine symptom has been related to…

Why Do I Have Migraine or Why Does My Head Hurt so Bad?

September 2022, Episode 133: Lindsay Weitzel, PhD, and Amelia Scott Barrett, MD, discuss why we get migraine and where it starts. Can we reverse course through medications, lifestyle, diet, or even our thoughts and mentality to change our migraine and…

New Data Shows Delay in Anti-CGRP Medication Response for Some

July 2022, Episode 129: Have you been failed by the anti-CGRP monoclonal antibody treatments? How long did you trial them before deciding they did not work? Brand new data presented at last month’s American Headache Society meeting shows that a…

Migraine Medication Failures

June 2022, Episode 126: Have you had a migraine medication fail you? Or have multiple migraine medications failed you? How did it make you feel? In this episode of Heads UP Lindsay Weitzel, Ph.D. talks to Melissa Geraghty Psy.D. about…

Treating Migraine With Infusions

March 2022, Episode 116: In this week’s episode of Heads UP Lindsay Weitzel, Ph.D. discusses infusions with Dr. Merle Diamond, MD. What infusions are used to break a migraine cycle and why? What medicines are sometimes added together in the…

Topiramate vs Erenumab

January 2022, Episode 110: The HER-MES trial is a newly published study comparing the tolerability and efficacy of topiramate (Topamax) and erenumab (Aimovig). The results of this trial could impact prescribing practices and payor policies. Tune in this afternoon for…

DATA Alert on Intranasal Zavegepant

January 2022, Episode 109: New Data Alert on the Up-and-Coming Migraine Medication: Intranasal Zavegepant. While not yet approved for release, intranasal zavegepant has shown promise in some interesting and unique data points in the relief of acute migraine. What is…

Atogepant and Migraine

October 2021, Episode 103: Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard…

New and Emerging Migraine Medications

I find this to be the most interesting time of year for me to be writing this particular article. This is because of the spring flowers blooming outside right now. The flowers have special meaning to me when it comes…

New Drug Data Alert – Atogepant

August 2020, Episode 69: New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness. How will we take it and how often?…

Treatment Optimization and Medication Side Effects

July 2020, Episode 63: Do you feel your migraine treatment options are limited because you experience numerous side effects to multiple medications? Dr. Lindsay Weitzel talks to Dr. Vince Martin about how to optimize your treatment plan if you are…

Next ›